A 67-year-old man with a history of ascending thoracic aneurysm, asthma, and schizophrenia presented with tachypnea after cardiac catheterization. Exam showed increased work of breathing. Blood cultures grew methicillin-susceptible Staphylococcus aureus (MSSA), which was treated with intravenous cefazolin. Despite treatment, the patient remained persistently bacteremic. An exhaustive search for a source proved unfruitful; notably, a transthoracic echocardiogram (TTE) showed no evidence of endocarditis. A whole-body PET/CT was then conducted to evaluate for occult sources. This study showed a T2 vertebrae with osteomyelitis (red arrow), right glenohumeral edema with soft tissue infection (yellow arrows), and a 4.8-cm infrarenal mycotic aortic aneurysm (white arrows).
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.